000153 豐原藥業
按盤價 
6.450 -0.020 (-0.309%)
6.450 -0.020 (-0.309%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 1.727 | 4.822 | 8.229 | 8.805 | 8.900 |
| 總資產報酬率 ROA (%) | 0.709 | 2.038 | 3.539 | 3.595 | 3.622 |
| 投入資產回報率 ROIC (%) | 0.946 | 2.778 | 5.065 | 5.265 | 5.242 | 邊際利潤分析 |
| 銷售毛利率 (%) | 22.899 | 18.374 | 21.763 | 25.708 | 28.228 |
| 營業利潤率 (%) | 5.318 | 3.267 | 4.787 | 4.988 | 5.047 |
| 息稅前利潤/營業總收入 (%) | 5.993 | 4.082 | 5.547 | 5.629 | 5.799 |
| 淨利潤/營業總收入 (%) | 4.359 | 2.457 | 3.679 | 3.679 | 3.770 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 93.293 | 92.805 | 74.509 | 82.302 | 76.544 |
| 價值變動淨收益/利潤總額(%) | -0.270 | 4.718 | 1.886 | -0.735 | 7.327 |
| 營業外收支淨額/利潤總額(%) | -0.036 | -0.701 | 1.740 | 0.763 | 0.096 | 償債能力分析 |
| 流動比率 (X) | 0.897 | 0.882 | 0.898 | 0.945 | 0.886 |
| 速動比率 (X) | 0.671 | 0.653 | 0.627 | 0.660 | 0.588 |
| 資產負債率 (%) | 58.980 | 57.981 | 56.460 | 56.304 | 60.737 |
| 帶息債務/全部投入資本 (%) | 38.697 | 37.587 | 31.784 | 27.448 | 36.839 |
| 股東權益/帶息債務 (%) | 140.348 | 147.162 | 189.414 | 229.778 | 153.594 |
| 股東權益/負債合計 (%) | 68.875 | 71.723 | 76.123 | 76.417 | 63.677 |
| 利息保障倍數 (X) | 8.851 | 4.875 | 8.209 | 9.334 | 7.765 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 110.151 | 89.793 | 72.514 | 62.472 | 60.872 |
| 存貨周轉天數 (天) | 79.318 | 65.000 | 62.648 | 72.125 | 84.810 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 30/04/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
